Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A.

Blood
Manuel BuscarletLambert Busque

Abstract

We analyzed DNA from polymorphonuclear (PMN) cells, monocytes, B cells, and T cells of 107 individuals with clonal hematopoiesis of indeterminate potential (CHIP) to perform lineage restriction analysis of different gene mutations. Three lineage categories were defined: myeloid (PMN with or without monocytes), myelolympho-B (myeloid and B cells), and multipotent (myeloid, B and T cells). Six individuals with aberrant patterns were excluded from analysis. Ninety-four had a single mutation (56 in DNMT3A, 24 in TET2, 7 in other genes [JAK2, ASXL1, CBL or TP53]). Fourteen had multiple mutations. The lineage restriction patterns of single DNMT3A- or TET2-mutated individuals were different. The proportion of myeloid restricted mutations was higher for TET2 (54.2%, 13 of 24) than for DNMT3A (23.2%, 13 of 56) (P < .05). It was similar for myelolympho-B category but with a 1.5 fold greater proportion of myeloid cells for TET2 individuals (P < .05). Importantly, 0% (0 of 24) of the individuals with TET2 mutation in the multipotent category in contrast to 35.7% (20 of 56) for DNMT3A (P < .01). The clone size predicted multipotent pattern for DNMT3A suggesting a time delay for extensive lineage clonal dominance. These distinctive features ...Continue Reading

References

Dec 6, 2011·Nature Genetics·Grant A ChallenMargaret A Goodell
Nov 27, 2014·The New England Journal of Medicine·Siddhartha JaiswalBenjamin L Ebert
Nov 27, 2014·The New England Journal of Medicine·Giulio GenoveseSteven A McCarroll
Aug 19, 2016·Nature Communications·Pierre HirschFrançois Delhommeau
Aug 23, 2016·Nature Communications·Andrew L YoungTodd E Druley
Dec 20, 2016·Nature Genetics·Hideki MakishimaJaroslaw P Maciejewski
Mar 21, 2017·Nature Cell Biology·Lars VeltenLars M Steinmetz
Jun 22, 2017·The New England Journal of Medicine·Siddhartha JaiswalBenjamin L Ebert
Mar 2, 2018·Leukemia·Christopher Maximilian ArendsFrederik Damm

❮ Previous
Next ❯

Citations

Sep 7, 2018·Circulation Journal : Official Journal of the Japanese Circulation Society·Soichi SanoKenneth Walsh
Aug 21, 2018·Current Opinion in Hematology·Sagi Abelson, Jean C Y Wang
Jun 13, 2019·Molecular Genetics & Genomic Medicine·Elena BussagliaPablo Fuentes-Prior
Jan 15, 2020·Cold Spring Harbor Perspectives in Biology·Lara Al Zouabi, Allison J Bardin
Apr 2, 2020·Experimental Hematology & Oncology·Jifeng YuZhongxing Jiang
Apr 3, 2019·Genes, Chromosomes & Cancer·Luise Hartmann, Klaus H Metzeler
Aug 5, 2020·Journal of Clinical Medicine·Veronica PapaFrancesco Vieceli Dalla Sega
Feb 26, 2020·Blood Advances·Christopher J Gibson, R Coleman Lindsley
Jul 5, 2019·Nature Reviews. Molecular Cell Biology·Ewa M MichalakMark A Dawson
Jul 6, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Anuradha KirtoniaManoj Garg
Dec 21, 2019·Haematologica·Paula SavolaSatu Mustjoki
Nov 12, 2019·JACC. Basic to Translational Science·Soichi SanoKenneth Walsh
Jun 12, 2020·Mechanisms of Ageing and Development·Maria Terradas-TerradasKristina Kirschner
Feb 2, 2021·Circulation·Silvia Mas-PeiroAndreas M Zeiher
Oct 30, 2020·International Journal of Molecular Sciences·Oleg Kandarakov, Alexander Belyavsky
Nov 7, 2020·Circulation Research·Wesley Tyler AbplanalpStefanie Dimmeler
Feb 1, 2020·Experimental Hematology·Elina K CookMichael J Rauh
Dec 2, 2020·Haematologica·Paula SavolaSatu Mustjoki
May 11, 2021·The Journal of Experimental Medicine·Jung-Yeon LimMinji Byun
Nov 14, 2020·Leukemia·Erik B van den AkkerHenne Holstege
Jul 8, 2021·Cancer Discovery·Alessandra VenanziEnrico Tiacci
Jul 24, 2021·Journal of Molecular and Cellular Cardiology·Christopher S MarnellPradeep Natarajan
Jun 25, 2021·Cardiovascular Research·Ying WangKenneth Walsh
Jul 4, 2021·Leukemia·Malte von BoninMartin Bornhäuser
Nov 19, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher J GibsonR Coleman Lindsley
Jan 15, 2022·Bone Marrow Transplantation·Johannes Frasez SoerensenMaja Ludvigsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease & TET2

Cardiovascular diseases are the number one cause of deaths globally. Tet methylcytosine dioxygenase 2 (TET2)-mediated hematopoiesis has been implicated in accelerating heart failure. Here is the latest research on cardiovascular diseases and TET2.